Analysis

Nigeria’s HIV ‘breakthrough’: separating truth from hope

Nigeria’s HIV ‘breakthrough’: separating truth from hope

Pharma Technology Focus – Issue 56

Pharma Technology Focus – Issue 56

Why the UK NHS needs clinical research

Why the UK NHS needs clinical research

Pharma payments to doctors: seeking transparency

Pharma payments to doctors: seeking transparency

How does the NHS weigh the costs of HIV preventing drugs?

How does the NHS weigh the costs of HIV preventing drugs?

Pharma Technology Focus – Issue 54

Pharma Technology Focus – Issue 54

Debating the value of targeted lung cancer treatments

Debating the value of targeted lung cancer treatments

Tackling false trial data in China

Tackling false trial data in China

Ketamine: taking aim at depression

Ketamine: taking aim at depression

Pharma Technology Focus – Issue 53

Pharma Technology Focus – Issue 53

Bernie vs. Big Pharma

Bernie vs. Big Pharma

Antibiotic resistance: the race for the prize

Antibiotic resistance: the race for the prize

Open debate: is it ever justified to withhold clinical trial data?

Open debate: is it ever justified to withhold clinical trial data?

Pharma Technology Focus – Issue 52

Pharma Technology Focus – Issue 52

Is the stage set for global drug price regulation?

Is the stage set for global drug price regulation?

Pharma Technology Focus – Issue 50

Pharma Technology Focus – Issue 50

Xilonix: new anti-tumour cancer drug is on the fast-track

Xilonix: new anti-tumour cancer drug is on the fast-track

ChemoFilter: getting the drugs back out

ChemoFilter: getting the drugs back out

Psilocybin vs. depression: London study overcomes obstacles to show encouraging results

Psilocybin vs. depression: London study overcomes obstacles to show encouraging results

Watching the clock: should day and night influence our drug regimens?

Watching the clock: should day and night influence our drug regimens?

July's top stories: Cancer Drugs Fund implemented in UK, Nichi-Iko acquired Sagent Pharmaceuticals

July's top stories: Cancer Drugs Fund implemented in UK, Nichi-Iko acquired Sagent Pharmaceuticals
cachename:Featurescachekey:rd-137342983_1031809799_rd-1665407042_727740091_rd-488908060_1460672566_ap1460672566_727740091_1492331643